Ribometrix
PrivateLast Round
Strategic
Jan 6, 2021
Total Funding Raised
$45.79M
Momentum Score
25 /100
Company Overview
Ribometrix is a biotechnology company that develops small molecule therapeutics designed to modulate RNA biology for the treatment of human diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ribometrix Comps
Public and private peers based on sector, stage, and business model.
Ribometrix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jan 6, 2021 | ||||
| Strategic | Sep 30, 2019 | ||||
| Series A Extension | Sep 27, 2019 | ||||
| Series A | Nov 13, 2018 | ||||
| Seed | Oct 31, 2017 |
Key People
Founding team and executive leadership
Ribometrix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SV Health Investors | Series A, Seed |
| Pappas Capital | Series A |
| MP Healthcare Venture Management | Seed, Series A |
| NIH RADx | Grant |
| Genentech | Strategic |
| M Ventures | Series A |
| Hatteras Venture Partners | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 9, 2025
Katie Warner appointed as new Chief Scientific Officer.
- Jan 9, 2025
William S. Marshall, Ph.D. named new Chief Executive Officer.
Ribometrix Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ribometrix's valuation, stock price, and market status.
